Updated antithrombotic strategies to reduce the burden of cardiovascular recurrences in patients with chronic coronary syndrome
Despite recent achievements in secondary cardiovascular prevention, the risk of further events in patients with chronic coronary syndromes (CCS) remains elevated. Highest risk is seen in patients with recurrent events, comorbidities or multisite atherosclerosis. Optimising antithrombotic strategies...
Main Authors: | Giuseppe Patti, Francesco Fattirolli, Leonardo De Luca, Giulia Renda, Rossella Marcucci, Guido Parodi, Gian Piero Perna, Felicita Andreotti, Chiara Ghiglieno, Francesco Fedele, Niccolò Marchionni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221005655 |
Similar Items
-
Management of Antithrombotic in Endoscopic Procedures
by: Dwi Suseno, et al.
Published: (2018-03-01) -
Risk of Gastrointestinal Bleed and Endoscopic Procedures on Antiplatelet and Antithrombotic Agents
by: Partha Pal, et al.
Published: (2019-01-01) -
Does antithrombotic prophylaxis worsen early outcomes of total thyroidectomy? - a retrospective cohort study
by: E. Erdas, et al.
Published: (2019-04-01) -
Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit
by: Rafael Consolin Chelucci, et al.
Published: (2014-02-01) -
Bleeding risk in endoscopic retrograde cholangiopancreatography: impact of the use of antithrombotic drugs
by: Fernando Alberca-de-las-Parras, et al.